Dank, i think investors, large and small, are positioning themselves for some major development. The strong uptrend and impressive volume all verify this. The phase 2b results have barely been out for four weeks. I don't think a 2 month wait is unreasonable.
tj, if you're serious about investing in Avexa then you should read some of the analyst reports and their DCF valuations and perhaps apply your own discounted valuations based on what you believe to be a very limited upside. It's one thing to say something is overvalued but what do you consider to be a fair value? If you do answer this question could you please include your WACC percentage figure, your Beta value, the equity risk premium that you have used, the risk free ratio that you have used and the long run growth rate that you have used Also could you please include some studies that support your assumptions on NRTI's. thanks
AVX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held